Bilirubin value in newborns can make a decisive contribution to an optimal therapy. Not only the time-point, on which a therapy should be started, but also the length of time a baby requires treatment with phototherapy can be managed by bilispect^®.

In opposition to the existing non-invasive bilirubin analyzers bilispect^® measures the quantitative bilirubin content in the blood as well as the transcutaneous bilirubin value in the skin!

Advantages:

• high accuracy by measuring the bilirubin value directly in the blood
• a reliable decision to start a therapy and continue with treatment
• long-term monitoring during the phototherapy using a button sensor
• appreciate for all newborns
• no infection risk, no stress for infants
• no disposable materials
• minimization of operating costs